Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 190

1.

Molecular patterns in deficient mismatch repair colorectal tumours: results from a French prospective multicentric biological and genetic study.

Etienne-Grimaldi MC, Mahamat A, Chazal M, Laurent-Puig P, Olschwang S, Gaub MP, Formento JL, Formento P, Sudaka A, Boige V, Abderrahim-Ferkoune A, Benchimol D, André T, Houry S, Faucheron JL, Letoublon C, Gilly FN, Delpero JR, Lasser P, Pradere B, Pezet D, Penault-Llorca F, Milano G.

Br J Cancer. 2014 May 27;110(11):2728-37. doi: 10.1038/bjc.2014.213. Epub 2014 May 6.

PMID:
24800948
[PubMed - indexed for MEDLINE]
2.

High-resolution analysis of DNA copy number alterations in rectal cancer : Correlation with metastasis, survival, and mRNA expression.

Doyen J, Letouzé E, Marisa L, de Reyniès A, Milano G, Etienne-Grimaldi MC, Olschwang S, Gaedcke J, Ghadimi M, Gérard JP.

Strahlenther Onkol. 2014 Apr 26. [Epub ahead of print]

PMID:
24770938
[PubMed - as supplied by publisher]
3.

The UMD-APC database, a model of nation-wide knowledge base: update with data from 3,581 variations.

Grandval P, Blayau M, Buisine MP, Coulet F, Maugard C, Pinson S, Remenieras A, Tinat J, Uhrhammer N, Béroud C, Olschwang S.

Hum Mutat. 2014 May;35(5):532-6. doi: 10.1002/humu.22539. Epub 2014 Apr 7.

PMID:
24599579
[PubMed - in process]
4.

A multicenter blinded study evaluating EGFR and KRAS mutation testing methods in the clinical non-small cell lung cancer setting--IFCT/ERMETIC2 Project Part 1: Comparison of testing methods in 20 French molecular genetic National Cancer Institute platforms.

Beau-Faller M, Blons H, Domerg C, Gajda D, Richard N, Escande F, Solassol J, Denis MG, Cayre A, Nanni-Metellus I, Olschwang S, Lizard S, Piard F, Pretet JL, de Fraipont F, Bièche I, de Cremoux P, Rouquette I, Bringuier PP, Mosser J, Legrain M, Voegeli AC, Saulnier P, Morin F, Pignon JP, Zalcman G, Cadranel J.

J Mol Diagn. 2014 Jan;16(1):45-55. doi: 10.1016/j.jmoldx.2013.07.009. Epub 2013 Oct 30.

PMID:
24183959
[PubMed - in process]
5.

Lack of referral for genetic counseling and testing in BRCA1/2 and Lynch syndromes: a nationwide study based on 240,134 consultations and 134,652 genetic tests.

Pujol P, Lyonnet DS, Frebourg T, Blin J, Picot MC, Lasset C, Dugast C, Berthet P, de Paillerets BB, Sobol H, Grandjouan S, Soubrier F, Buecher B, Guimbaud R, Lidereau R, Jonveaux P, Houdayer C, Giraud S, Olschwang S, Nogue E, Galibert V, Bara C, Nowak F, Khayat D, Nogues C.

Breast Cancer Res Treat. 2013 Aug;141(1):135-44. doi: 10.1007/s10549-013-2669-9. Epub 2013 Aug 24.

PMID:
23974829
[PubMed - indexed for MEDLINE]
6.

UMD-MLH1/MSH2/MSH6 databases: description and analysis of genetic variations in French Lynch syndrome families.

Grandval P, Fabre AJ, Gaildrat P, Baert-Desurmont S, Buisine MP, Ferrari A, Wang Q, Béroud C, Olschwang S.

Database (Oxford). 2013 May 31;2013:bat036. doi: 10.1093/database/bat036. Print 2013.

PMID:
23729658
[PubMed - indexed for MEDLINE]
Free PMC Article
7.

Gene expression classification of colon cancer into molecular subtypes: characterization, validation, and prognostic value.

Marisa L, de Reyniès A, Duval A, Selves J, Gaub MP, Vescovo L, Etienne-Grimaldi MC, Schiappa R, Guenot D, Ayadi M, Kirzin S, Chazal M, Fléjou JF, Benchimol D, Berger A, Lagarde A, Pencreach E, Piard F, Elias D, Parc Y, Olschwang S, Milano G, Laurent-Puig P, Boige V.

PLoS Med. 2013;10(5):e1001453. doi: 10.1371/journal.pmed.1001453. Epub 2013 May 21.

PMID:
23700391
[PubMed - indexed for MEDLINE]
Free PMC Article
8.

[Desmoid tumors in children: current strategy].

Oudot C, Defachelles AS, Minard-Colin V, Olschwang S, Fourcade L, Helfre S, Orbach D.

Bull Cancer. 2013 May;100(5):518-28. doi: 10.1684/bdc.2013.1747. Review. French.

PMID:
23695183
[PubMed - indexed for MEDLINE]
9.

Gastric Adenocarcinoma in Familial Adenomatous Polyposis Can Occur Without Previous Lesions.

Ravoire A, Faivre L, Degrolard-Courcet E, Bedenne L, Olschwang S, Rat P, Ortega-Deballon P.

J Gastrointest Cancer. 2013 May 16. [Epub ahead of print] No abstract available.

PMID:
23677534
[PubMed - as supplied by publisher]
10.

Design of a core classification process for DNA mismatch repair variations of a priori unknown functional significance.

Grandval P, Fabre AJ, Olschwang S.

Hum Mutat. 2013 Jun;34(6):920-2. doi: 10.1002/humu.22312. Epub 2013 Mar 28. No abstract available.

PMID:
23554159
[PubMed - indexed for MEDLINE]
11.

Semiparametric inference on the penetrances of rare genetic mutations based on a case-family design.

Zhang H, Zeng D, Olschwang S, Yu K.

J Stat Plan Inference. 2013 Feb;143(2):368-377.

PMID:
23329866
[PubMed]
Free PMC Article
12.

Towards a "Lyon molecular signature" to individualize the treatment of rectal cancer. Prognostic analysis of a prospective cohort of 94 rectal cancers T1-2-3 Nx MO to be the basis of a molecular signature.

Gérard JP, Baulieux J, Doyen J, Gal J, Letouze E, Olschwang S, Chapet O, Romestaing P.

Cancer Radiother. 2012 Dec;16(8):688-96. doi: 10.1016/j.canrad.2012.09.003. Epub 2012 Nov 13.

PMID:
23153504
[PubMed - indexed for MEDLINE]
13.

Long-term effect of resistant starch on cancer risk in carriers of hereditary colorectal cancer: an analysis from the CAPP2 randomised controlled trial.

Mathers JC, Movahedi M, Macrae F, Mecklin JP, Moeslein G, Olschwang S, Eccles D, Evans G, Maher ER, Bertario L, Bisgaard ML, Dunlop M, Ho JW, Hodgson S, Lindblom A, Lubinski J, Morrison PJ, Murday V, Ramesar R, Side L, Scott RJ, Thomas HJ, Vasen H, Gerdes AM, Barker G, Crawford G, Elliott F, Pylvanainen K, Wijnen J, Fodde R, Lynch H, Bishop DT, Burn J; CAPP2 Investigators.

Lancet Oncol. 2012 Dec;13(12):1242-9. doi: 10.1016/S1470-2045(12)70475-8. Epub 2012 Nov 7.

PMID:
23140761
[PubMed - indexed for MEDLINE]
Free Article
14.

A seven-gene signature aggregates a subgroup of stage II colon cancers with stage III.

Laibe S, Lagarde A, Ferrari A, Monges G, Birnbaum D, Olschwang S; COL2 Project.

OMICS. 2012 Oct;16(10):560-5. doi: 10.1089/omi.2012.0039. Epub 2012 Aug 23.

PMID:
22917480
[PubMed - indexed for MEDLINE]
15.

Clinical utility gene card for: Lynch syndrome (MLH1, MSH2, MSH6, PMS2, EPCAM) - update 2012.

Rahner N, Steinke V, Schlegelberger B, Eisinger F, Hutter P, Olschwang S.

Eur J Hum Genet. 2013 Jan;21(1). doi: 10.1038/ejhg.2012.164. Epub 2012 Aug 15. No abstract available.

PMID:
22892529
[PubMed - indexed for MEDLINE]
Free PMC Article
16.

Is the controversy on breast cancer as part of the Lynch-related tumor spectrum still open?

Grandval P, Barouk-Simonet E, Bronner M, Buisine MP, Moretta J, Tinat J, Olschwang S.

Fam Cancer. 2012 Dec;11(4):681-3. doi: 10.1007/s10689-012-9562-2.

PMID:
22890886
[PubMed - indexed for MEDLINE]
17.

8q24 Cancer risk allele associated with major metastatic risk in inflammatory breast cancer.

Bertucci F, Lagarde A, Ferrari A, Finetti P, Charafe-Jauffret E, Van Laere S, Adelaide J, Viens P, Thomas G, Birnbaum D, Olschwang S.

PLoS One. 2012;7(5):e37943. doi: 10.1371/journal.pone.0037943. Epub 2012 May 29.

PMID:
22666420
[PubMed - indexed for MEDLINE]
Free PMC Article
18.

Expression Profiles in Stage II Colon Cancer According to APC Gene Status.

Birnbaum DJ, Laibe S, Ferrari A, Lagarde A, Fabre AJ, Monges G, Birnbaum D, Olschwang S; COL2 Project.

Transl Oncol. 2012 Apr;5(2):72-6. Epub 2012 Apr 1.

PMID:
22496922
[PubMed]
Free PMC Article
19.

KRAS mutation spectrum notably diverges between non-small cell lung and colorectal carcinomas.

Compagnone M, Chetaille B, Olschwang S.

J Thorac Oncol. 2012 Apr;7(4):773-4; author reply 774. doi: 10.1097/JTO.0b013e318245a9c5. No abstract available.

PMID:
22425934
[PubMed - indexed for MEDLINE]
20.

Colon-specific phenotype in Lynch syndrome associated with EPCAM deletion.

Grandval P, Baert-Desurmont S, Bonnet F, Bronner M, Buisine MP, Colas C, Noguchi T, North MO, Rey JM, Tinat J, Toulas C, Olschwang S.

Clin Genet. 2012 Jul;82(1):97-9. doi: 10.1111/j.1399-0004.2011.01826.x. Epub 2012 Jan 16. No abstract available.

PMID:
22243433
[PubMed - indexed for MEDLINE]

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk